Conversely, increased CD8+ lymphocyte aggregation at the tumour margin after CRT was rarely observed in cancers with a low density of CD8+ TILs in pretreatment biopsy specimens9, which prevented downstaging. The gene discussed is CD8A; the disease is cancer.